Low prevalence of islet autoimmunity in adult diabetes and low predictive value of islet autoantibodies in the general adult population of northern Italy

Diabetologia

Volumn 42, Issue 7, 1999, Pages 840-844

  Bosi, E ^a   Garancini, M P ^b   Poggiali, F ^b   Bonifacio, E ^b   Gallus, G ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b NONE

Author keywords

Autoantibodies; Epidemiology; Prediction; Type I diabetes; Type II diabetes

Indexed keywords

AUTOANTIBODY; GLUCOSE; GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ADULT; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; ITALY; MAJOR CLINICAL STUDY; PANCREAS ISLET; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; ANTIBODIES; AUTOANTIBODIES; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; FOLLOW-UP STUDIES; GLUTAMATE DECARBOXYLASE; HUMANS; ISLETS OF LANGERHANS; ITALY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEIN-TYROSINE-PHOSPHATASE; RISK FACTORS;

EID: 0032764983     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051235     Document Type: Article

References (10)

1. 1. Garancini MP, Calori G, Ruotolo G et al. (1995) Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study. Diabetologia 38: 306-313
2. 2. Hagopian WA, Karlsen AE, Gottsater A et al. (1993) Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 91: 368-374
3. 3. Turner R, Stratton I, Horton V et al. (1997) UKPDS 25: autoantibodies to islet cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 350: 1288-1293
4. 4. Tuomi T, Carlsson AL, Li H et al. (1999). Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48: 150-157
5. 5. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E (1995) Identification of Protein Tyrosine Phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a component of islet cell antibodies. J Immunol 155: 5419-5426
6. 6. Naserke HE, Dozio N, Ziegler AG, Bonifacio E (1998) Comparison of a novel microassay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia 41: 681-683
7. 7. Garancini MP, Sergi A, Lazzari P, Gallus G (1995) Epidemiology of known diabetes in Lombardy, north Italy. Clinical characteristics and methodological aspects. Acta Diabetol 32: 268-272
8. 8. Ruige JB, Batstra MR, Aanstoot HJ et al. (1997) Low prevalence of antibodies to GAD65 in a 50 to 74 year old general dutch population. Diabetes Care 20: 1108-1110
9. 9. Green A, Gale EAM, Patterson CC, for the EURODIAB ACE Study Group (1992) Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study Group. Lancet 339: 905-909
10. 10. Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM (1997) Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46: 1701-1710